ESOPHAGEAL CANCER NEWS TIPS & FEATURES


OMNI Health Media is a leading online provider of Daily Health News. OMNI’s News Tips And Features Other News provides summaries of developments in the prevention, screening, and management of Gastrointestinal Health Conditions as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating new therapies and supportive care strategies in order to better educate patients and their caregivers, ensuring timely access to the best care available.

December 1st, 2017

Diagnosed with Esophageal Cancer: 10 Tips on How to Get The Most From Your Doctor

By Anonymous User anonymous_user_10987

1) Choose Your Doctor Carefully Surgeons, medical oncologists and radiation oncologists are the primary doctors involved with esophageal cancer and often work in collaboration. Pick your primary oncologist carefully, rely on people you trust including nurses and other health care professionals who make help with recommendations.  Make sure your doctor is someone you feel comfortable […]

View full entry

Tags: Esophageal Cancer, News Tips and Features, News Tips and Features Other


Does Long-term use of Proton Pump Inhibitors as Treatment for Ulcers Increases Risk for Gastric Cancer?

November 27th, 2017

Does Long-term use of Proton Pump Inhibitors as Treatment for Ulcers Increases Risk for Gastric Cancer?

By cancerconnect cancerconnect

The use of a proton-pump inhibitor (PPI) medication after Helicobacter pylori eradication appears to more than doubles the risk for developing gastric cancer, according to a recent study published in the medical journal Gut.1 About Proton pump inhibitors. This group of drugs, which includes Nexium® (esomeprazole), Prevacid® (lansoprazole), Prilosec® (omeprazole), and others reduces stomach acidity by blocking […]

View full entry

Tags: esomeprazole, Gastric Cancer, gastric Ulcer, heliobacter pylori, lansoprazole, News Tips and Features, News Tips and Features Other, Nexium, omeprazole, Prevacid, Prilosec, proton pump inhibitors


Orphan Drug Act: Rare Disease Patients Find Their “Voice,” Fight for Innovation

November 1st, 2017

Orphan Drug Act: Rare Disease Patients Find Their “Voice,” Fight for Innovation

By cancerconnect cancerconnect

There Are More Patients Living with Rare Diseases Than the Combined Number of Patients Living With HIV, Heart Disease, Or Stroke. By Terry Wilcox A year before she was hitting the high notes on national television, Felicia Temple was feeling low. “I didn’t really know what was going on with me, but I knew I […]

View full entry

Tags: News Tips and Features, News Tips and Features Other


Inflammatory Bowel Disease is Associated with Increased risk of other Immune Mediated Diseases

October 17th, 2017

Inflammatory Bowel Disease is Associated with Increased risk of other Immune Mediated Diseases

By cancerconnect cancerconnect

A Danish National Patient Registry based analyses has shown higher rates of immune mediated diseases (IMD) in patients with inflammatory bowel disease (IBD). Inflammatory Bowel Disease is an immune-mediated chronic inflammation of the gastrointestinal tract. Normally, the cells and proteins that make up the immune system protect you from infection. In people with IBD, however, […]

View full entry

Tags: ankylosing spondylitis, Asthma, Celiac Disease, immune mediated disease, Inflammatory Bowel Disease, Iridocyclitis, News Tips and Features, News Tips and Features Other, Primary sclerosing cholangitis, psoriasis, Pyoderma gangrenosum, rheumatoid arthritis


Flu Shot 101 – What You Need to Know

October 17th, 2017

Flu Shot 101 – What You Need to Know

By cancerconnect cancerconnect

Flu season is here again, and besides a fever and runny nose, it can bring about the longtime controversy surrounding vaccines. In order to protect more human lives this year and to clarify some of the most common misconceptions surrounding the flu vaccine, the team at ConsumerSafety.org met with Dr. William Schaffner, an infectious disease […]

View full entry

Tags: flu vaccine, Influenza, News Tips and Features, News Tips and Features Other


Ask the Expert: Focus on Ankylosing Spondylitis

October 16th, 2017

Ask the Expert: Focus on Ankylosing Spondylitis

By megm megm

The SpineCommunity Presents: Ask the Expert with Dr. David Borenstein David G. Borenstein, MD recently answered your questions on ankylosing spondylitis (AS) in TheSpineCommunity.  TheSpineCommunity is an online support community for individuals affected with conditions of the spine, join the conversation here. Question: What are the best exercises for ankylosing spondylitis? Dr. Borenstein:  The difficulty […]

View full entry

Tags: ankylosing spondylitis, AS, crohn's, crohn's disease, crohns disease ulcerative colitis, crohn’s ulcerative colitis, Exercise, IL17 inhibitors, iritis, neuropathy, News Tips and Features, News Tips and Features Other


October 16th, 2017

Targeting both BRAF and EGFR doubles progression-free survival in metastatic colorectal cancer

By Anonymous User anonymous_user_10987

Recent successes in genetically targeted precision cancer medicines are improving outcomes in a number of cancers.  Ensuring patients undergo genomic sequencing to determine if they have treatable targets is increasingly important to ensure patients receive the most appropriate personalized care. Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormalities in […]

View full entry

Tags: BRAF, Colon Cancer, erbitux, News Tips and Features, News Tips and Features Other, Precision Cancer Medicine, Rectal Cancer, V600E, vemurafenib, Zelboraf


New Standard of Care for Treatment of Resectable Gastric Cancer

October 3rd, 2017

New Standard of Care for Treatment of Resectable Gastric Cancer

By Anonymous User anonymous_user_10987

The superiority of docetaxel based triplet therapy over standard care in patients with resectable esophago-gastric cancer has been confirmed in late-breaking results from the FLOT4 trial presented at the ESMO 2017 Congress in Madrid.1 Survival in resectable esophago-gastric cancer is poor. Five-year overall survival is around 25% with surgery, and is increased to 36% by […]

View full entry

Tags: Esophageal Cancer, esophago-gastric cancer, Gastric Cancer, News Tips and Features, News Tips and Features Other


View more articles like this
More news and in-depth Esophageal Cancer information

CONDITIONS OF THE GI TRACT